|
(PQ #8) Biomarkers of efficacy and adverse events due to treatment with immune checkpoint inhibitors
|
1R01CA231291-01
|
$533,211
|
|
WELLSTEIN, ANTON
|
GEORGETOWN UNIVERSITY
|
|
(PQ1) Adaptive immune and microbial mechanisms regulating Lynch syndrome penetrance
|
1R01CA231283-01
|
$501,220
|
|
LIPKIN, STEVEN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
(PQ1) The role of cell-to-cell variation in the penetrance of heritable mutant RAS hypodermal neoplasias
|
1R01CA219460-01A1
|
$397,573
|
|
MENDENHALL, ALEXANDER
|
UNIVERSITY OF WASHINGTON
|
|
(PQ11) Dietary strategies to enhance FOLFOX cancer therapies
|
1R21CA231255-01
|
$189,744
|
|
ROSENBERG, DANIEL
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
(PQ12) Enhancement of DNA repair in neurons via a targeted APE1 small molecule modifier to decrease and reverse chemotherapy-induced peripheral neuropathy (CIPN)
|
1R01CA231267-01
|
$460,814
|
|
FEHRENBACHER, JILL
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
(PQ2) PD-L1/PD-1 signals in aged hosts undergoing cancer immunotherapy
|
1R01CA231325-01
|
$572,540
|
|
CURIEL, TYLER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
(PQ3) UNDERSTANDING THE INTERACTIONS BETWEEN GERMLINE AND SOMATIC ALTERATIONS in the PATHOGENESIS OF GLIOMAS
|
1R01CA230712-01
|
$633,992
|
|
JENKINS, ROBERT
|
MAYO CLINIC ROCHESTER
|
|
(PQ4) - Tools for simultaneous disruption of multiple epigenetically silenced genes for studying their roles in tumorigenesis using ex vivo human and mouse colon organoid and in vivo mouse models
|
1R01CA230995-01
|
$374,578
|
|
EASWARAN, HARIHARAN
|
JOHNS HOPKINS UNIVERSITY
|
|
(PQ4) Novel tools for in vivo study of genetic interactions in cancer progression
|
1R01CA231112-01
|
$576,627
|
|
CHEN, SIDI
|
YALE UNIVERSITY
|
|
(PQ4) Quantitative and multiplexed analysis of gene function in cancer in vivo
|
1R01CA231253-01
|
$471,700
|
|
WINSLOW, MONTE
|
STANFORD UNIVERSITY
|
|
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
|
3R01CA194461-04S1
|
$7,505
|
|
PARK, KWON-SIK
|
UNIVERSITY OF VIRGINIA
|
|
(PQ5) Contribution of mitochondrial pathways to metabolic heterogeneity in molecular subtypes of Diffuse Large B Cell Lymphoma
|
1R01CA219850-01A1
|
$558,022
|
|
DANIAL, NIKA
|
DANA-FARBER CANCER INST
|
|
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
|
3R01CA208642-03S1
|
$71,387
|
|
SHACKELFORD, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
|
3R01CA208642-03S2
|
$83,925
|
|
SHACKELFORD, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ5) Investigation of intertumoral and intratumoral heterogeneity of mitochondrial apoptotic sensitivity
|
3R01CA205967-03S2
|
$230,366
|
|
LETAI, ANTHONY
|
DANA-FARBER CANCER INST
|
|
(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses
|
1R01CA216101-01A1
|
$670,933
|
|
SHADEL, GERALD
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
|
(PQ6)Nuclear receptor mechanisms in circadian disruption induced hepatocarcinogenesis
|
1R01CA230848-01
|
$442,560
|
|
FU, LONING
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ8) Predicting immune-related toxicity in the adjuvant melanoma setting with checkpoint inhibition
|
1R01CA231295-01
|
$481,288
|
|
OSMAN, IMAN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
(PQ9) Developing EZH2 Degraders for Treating Triple-Negative Breast Cancer
|
1R01CA230854-01
|
$249,841
|
|
JIN, JIAN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
1/2 Cherokee Nation/Stephenson Cancer Center Collaborative on Cancer Disparities
|
3P20CA202923-04S1
|
$32,990
|
|
KHAN, SOHAIL
|
CHEROKEE NATION
|
|
2018 Cell Death Gordon Research Conference and Gordon Research Seminar
|
1R13CA232392-01
|
$4,000
|
|
CHAN, FRANCIS
|
GORDON RESEARCH CONFERENCES
|
|
2018 In Vivo Magnetic Resonance Gordon Research Conference & Gordon Research Seminar
|
1R13EB026933-01
|
$5,000
|
|
SODICKSON, DANIEL
|
GORDON RESEARCH CONFERENCES
|
|
30th International Workshop on Retroviral Pathogenesis
|
1R13CA232205-01
|
$4,000
|
|
GREEN, PATRICK
|
OHIO STATE UNIVERSITY
|
|
5-hydroxymethylcytosine in human cancer
|
5R01CA160965-06
|
$394,250
|
$197,125
|
PFEIFER, GERD
|
VAN ANDEL RESEARCH INSTITUTE
|
|
A biomarker-driven strategy to guide the use of radiotherapy in non-small cell lung cancer
|
1R37CA222294-01A1
|
$366,000
|
|
ABAZEED, MOHAMED
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
A Data Resource for Analyzing Blood and Marrow Transplants
|
2U24CA076518-21
|
$990,209
|
|
HOROWITZ, MARY
|
MEDICAL COLLEGE OF WISCONSIN
|
|
A Federated Galaxy for user-friendly large-scale cancer genomics research
|
1U24CA231877-01
|
$823,902
|
|
GOECKS, JEREMY
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
A high efficiency imager for real-time lung cancer monitoring during radiotherapy
|
3R01CA188446-05S1
|
$256,320
|
|
BERBECO, ROSS
|
DANA-FARBER CANCER INST
|
|
A HTS Approach to Discover Guanine Nucleotide-Competitive Inhibitors of Oncogenic KRAS
|
1R01CA223495-01A1
|
$454,077
|
|
ROSSMAN, KENT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
A Microfluidics Approach to Investigate Tumor Cell Trafficking in Bone Marrow
|
5F32CA210540-02
|
$61,174
|
|
GLASER, DREW
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
A Mouse Model to Assess Long Term Immunotherapy-related Adverse Effects in Children
|
1R01CA227671-01A1
|
$431,631
|
|
ZHENG, PAN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
A multiplexed approach to improve tumoral targeting and chemotherapeutic treatment
|
1R01CA222802-01A1
|
$412,139
|
|
LAW, BENEDICT
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
A New Target for Chromatin Remodeler Defects in Cancer
|
1R35CA231993-01
|
$594,375
|
|
WALKER, CHERYL
|
BAYLOR COLLEGE OF MEDICINE
|
|
A novel approach in Basal Cell Carcinoma treatment; targeting CRD-BP
|
1R03CA223099-01A1
|
$68,371
|
|
NOUBISSI, FELICITE
|
JACKSON STATE UNIVERSITY
|
|
A Novel Clinically Relevant Tumor Suppressor in Human Breast Cancer
|
1R03CA223709-01A1
|
$77,255
|
|
SPINELLA, MICHAEL
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
A Paradigm Shift in Chronic Lymphocytic Leukemia: Defining the Role of Hematopoietic Stem Cells in Leukemogenesis
|
1F30CA225070-01A1
|
$38,725
|
|
HU, EILEEN
|
OHIO STATE UNIVERSITY
|
|
A randomized trial of lifestyle guidelines on breast cancer biomarkers and treatment adherence
|
3R01CA207753-02S2
|
$76,309
|
|
SANFT, TARA
|
YALE UNIVERSITY
|
|
A Synthetic Bone Marrow to Understand Breast Cancer Dormancy
|
1R21CA223783-01A1
|
$161,059
|
|
PEYTON, SHELLY
|
UNIVERSITY OF MASSACHUSETTS AMHERST
|
|
A Unified Machine Learning Package for Cancer Diagnosis
|
1U01CA231782-01
|
$339,842
|
|
SHAPIRO, LINDA
|
UNIVERSITY OF WASHINGTON
|
|
Adaptation and implementation of a community-based intervention to reduce psychosocial distress and promote physical activity in rural breast cancer survivors
|
1K07CA222335-01A1
|
$165,681
|
|
MAMA, SCHEREZADE
|
PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
|
|
Addressing Sexual Concerns in Breast Cancer Survivors: RCT of a Novel Couple-Based Intervention
|
1R01CA222124-01A1
|
$601,848
|
|
REESE, JENNIFER
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Administrative Supplement: Nanoparticle Modified Human Fat Derived Mesenchymal Stem Cells for Brain Cancer
|
3R01CA195503-04S1
|
$55,777
|
|
QUINONES-HINOJOSA, ALFREDO
|
MAYO CLINIC JACKSONVILLE
|
|
Adoption, diffusion, and implementation of Tobacco 21 policies to address health disparities
|
1R01CA231139-01
|
$639,671
|
|
DELNEVO, CRISTINE
|
RBHS-SCHOOL OF PUBLIC HEALTH
|
|
Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology
|
3R33CA206949-02S1
|
$94,996
|
|
SPICER, TIMOTHY
|
SCRIPPS FLORIDA
|
|
An integrated approach to analyze and target EWS/FLI in Ewing sarcoma
|
1U54CA231641-01
|
$6,163,485
|
|
LESSNICK, STEPHEN
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
An integrative approach to identify neuroblastoma immunotherapeutic targets
|
1F31CA225069-01A1
|
$44,524
|
|
WEINER, AMBER
|
UNIVERSITY OF PENNSYLVANIA
|
|
An Ontology-driven Faceted Query Engine for the Kentucky Cancer Registry
|
1R21CA231904-01
|
$187,621
|
|
ZHANG, GUO-QIANG
|
UNIVERSITY OF KENTUCKY
|
|
Analysis of Racial Disparities in HCC by Systems Metabolomics
|
3U01CA185188-04S1
|
$67,546
|
|
RESSOM, HABTOM
|
GEORGETOWN UNIVERSITY
|
|
Androgen Deprivation Activates Wnt/Beta-Catenin Signaling in Prostate Cancer
|
1R01CA226285-01A1
|
$331,688
|
|
YU, XIUPING
|
LOUISIANA STATE UNIV HSC SHREVEPORT
|
|
Androgen Receptor and Intersecting Pathways Critical to Breast Cancer Subtypes
|
3R01CA187733-04S1
|
$68,962
|
|
RICHER-MOUCHANTAT, JENNIFER
|
UNIVERSITY OF COLORADO DENVER
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $16,663,479
|